The Effect Of Enamel Matrix Derivatives On Gingival Tissue Thickness

Part of paid clinical trials in San Antonio, Texas.

Sponsor
The University of Texas Health Science Center at San Antonio
Study ID
NCT07053969
Status
Recruiting

Conditions

  • Dental Implantation
  • Missing Teeth
  • Mucositis
  • Periodontitis, Adult

Eligibility Criteria

Sex
ALL
Age
18 Years - 18 Years
Healthy Volunteers
Accepted

Interventions

  • Enamel Matrix Derivative — DEVICE
    EMD is an FDA approved medical device used in periodontal procedures since 1996. It has been shown to enhance soft and hard tissue healing, increased root coverage and aid in periodontal regeneration. It's use as an adjunct during implant uncovering may increase peri-implant mucosal thickness.

Study Details

Scientists do research to answer important questions which might help change or improve the way we do things in the future. The investigators know that using Enamel Matrix Derivatives results in thicker gum tissues around teeth. This study will test to see if using EMD around implants results in thicker gum tissues around implants.

Key Dates

Start date
Aug 31, 2025
Status verified
Nov 2025
Primary completion
Sep 30, 2027
Completion
Sep 30, 2027

Study Design

Enrollment
32 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Group 1: Experimental Group using EMD
    During implant uncovering the experimental group will receive EMD under the buccal flap
  • No Intervention: Group 2: Control Group
    No EMD is administered under the buccal flap during suturing

Primary Outcome Measure

Mucosal Thickness [ Time Frame: One month and 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Texas Health Science Center at San AntonioSan AntonioTexas78229
Angela A Palaiologou-Gallis, DDS., MS.
210-567-3567

Find similar trials in San Antonio, TX

Related Studies